Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Plasma Cell Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03441958
What this trial is testing

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Ciusss de L'Est de l'Île de Montréal 19
Testing effectiveness (Phase 2)Ended earlyNCT00793650
What this trial is testing

Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study

Who this might be right for
CancerMultiple Myeloma
Emory University 39
Testing effectiveness (Phase 2)Study completedNCT03128359
What this trial is testing

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Who this might be right for
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center 38
Early research (Phase 1)Looking for participantsNCT06768489
What this trial is testing

JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaImmunoglobulin Light-chain Amyloidosis
Janssen Research & Development, LLC 276
Testing effectiveness (Phase 2)Study completedNCT00003353
What this trial is testing

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT00458653
What this trial is testing

Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Beth Israel Deaconess Medical Center 45
Testing effectiveness (Phase 2)Study completedNCT00307086
What this trial is testing

Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
H. Lee Moffitt Cancer Center and Research Institute 30
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT02903381
What this trial is testing

A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Dana-Farber Cancer Institute 8
Testing effectiveness (Phase 2)Looking for participantsNCT07053436
What this trial is testing

Horizon Two: HR NDMM (MMRC-100)

Who this might be right for
High Risk Newly Diagnosed Multiple Myeloma
Multiple Myeloma Research Consortium 300
Testing effectiveness (Phase 2)Study completedNCT02440464
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)

Who this might be right for
Multiple Myeloma
National Heart, Lung, and Blood Institute (NHLBI) 57
Large-scale testing (Phase 3)Study completedNCT00344526
What this trial is testing

Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis (AL)
University Hospital, Limoges 100
Testing effectiveness (Phase 2)Ended earlyNCT02967276
What this trial is testing

Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Campinas, Brazil 28
Testing effectiveness (Phase 2)Study completedNCT01040026
What this trial is testing

Expanded Natural Killer (NK) Cells for Multiple Myeloma Study

Who this might be right for
Multiple Myeloma
University Hospital, Basel, Switzerland 10
Not applicableStudy completedNCT02919670
What this trial is testing

A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin's Lymphoma
Dana-Farber Cancer Institute 114
Early research (Phase 1)Looking for participantsNCT06313502
What this trial is testing

High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders

Who this might be right for
Plasma Cell Disorder
University of Arkansas 18
Testing effectiveness (Phase 2)WithdrawnNCT03000634
What this trial is testing

2015-09: a Phase II Randomized, Open-label Study of Anti-signaling Lymphocytic Activation Molecule Monoclonal Antibody During Maintenance Therapy

Who this might be right for
Multiple Myeloma
University of Arkansas
Testing effectiveness (Phase 2)Ended earlyNCT02897830
What this trial is testing

Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus Lenalidomide Maintenance in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 46
Testing effectiveness (Phase 2)Study completedNCT01315132
What this trial is testing

Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

Who this might be right for
Hematological MalignanciesLeukemiaLymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT00869232
What this trial is testing

UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Who this might be right for
Multiple Myeloma
University of Arkansas 90
Next Page